ACADIA Pharmaceuticals logo

ACADIA Pharmaceuticals Funding & Investors

Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

acadia-pharm.com

Total Amount Raised: $121,600,000

ACADIA Pharmaceuticals Funding Rounds

  • Series F

    $25,000,000

    Series F Investors

    Federated Hermes
    Hambrecht & Quist Capital Management
    Forbion
    Oxford Bioscience Partners
    OrbiMed Advisors
    ABN AMRO Bank
    LD Pensions
  • Post Ipo Equity

    $86,385,000

  • Post Ipo Equity

    $287,500,000

  • Post Ipo Equity

    $316,249,997

  • Debt Financing

    $22,000,000

    Debt Financing Investors

    Pacific Rim Ventures
    H&Q Healthcare Investors
    The Kaufman Fund
    OrbiMed Advisors
    DKA Capital
  • Post Ipo Equity

    $15,000,000

    Post Ipo Equity Investors

    New Enterprise Associates (NEA)
    Venrock
  • Series D

    $10,700,000

    Series D Investors

    DKA Capital
    LD Pensions
  • Post Ipo Equity

    $287,500,000

  • Post Ipo Equity

    $316,249,997

  • Grant

    $2,400,000

    Grant Investors

    National Institute of Neurological Disorders and Stroke (NINDS)
  • Debt Financing

    $7,500,000

    Debt Financing Investors

    Vækstfonden
  • Post Ipo Equity

    $20,000,000

    Post Ipo Equity Investors

    Nomura
    Oxford Bioscience Partners
  • Post Ipo Equity

    $10,000,000

    Post Ipo Equity Investors

    Oxford Bioscience Partners
  • Series B

    $3,000,000

    Series B Investors

    BankInvest
    DKA Capital
    LD Pensions
  • Series A

    $6,000,000

    Series A Investors

    BankInvest
    DKA Capital
    LD Pensions
Funding info provided by Diffbot.